EG546143 Inhibitors
Pierce2, a protein encoded by the Pierce2 gene, plays a vital role in cellular processes associated with microtubule dynamics. Microtubules are essential components of the cytoskeleton, providing structural support and facilitating critical cellular functions such as intracellular transport, cell division, and maintenance of cell shape. Pierce2's expression in embryonic tissues and nodes suggests its significance in early developmental stages, where precise regulation of microtubule dynamics is crucial for proper cellular organization and differentiation. The function of Pierce2 hinges on its involvement in the modulation of microtubule dynamics. Microtubules undergo continuous polymerization and depolymerization, a process tightly regulated by various associated proteins, including Pierce2. As a "piercer of microtubule wall," Pierce2 likely participates in regulating microtubule stability and dynamics by influencing the intricate balance between polymerized and depolymerized states. This regulatory role positions Pierce2 as a key player in orchestrating cellular processes that rely on dynamic microtubules, contributing to the maintenance of cellular architecture and function.
Inhibition of Pierce2 function involves targeting the delicate equilibrium of microtubule dynamics. Chemicals that directly inhibit Pierce2 act by disrupting microtubule dynamics, either by promoting depolymerization or stabilizing microtubules. Indirect inhibitors, on the other hand, modulate microtubule stability, consequently impacting Pierce2 function. These mechanisms of inhibition highlight the interconnectedness between Pierce2 and microtubule dynamics, emphasizing the importance of maintaining proper microtubule organization for cellular homeostasis. The disruption of Pierce2 function through these inhibitors can lead to alterations in cellular processes that rely on dynamic microtubules, further underscoring the significance of Pierce2 in fundamental cellular activities. Investigating Pierce2 and its inhibition provides valuable insights into the intricate regulatory networks governing microtubule dynamics, contributing to our understanding of cellular physiology and early developmental processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This disruption interferes with Pierce2's role in maintaining microtubule structure, potentially leading to impaired cellular functions and processes dependent on microtubules. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol, a microtubule-stabilizing agent, indirectly inhibits Pierce2 by promoting microtubule stability. Enhanced microtubule stability interferes with Pierce2 function, potentially affecting cellular processes relying on dynamic microtubule structures. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This interference with microtubule structure can lead to functional impairment of Pierce2, affecting cellular processes dependent on dynamic microtubules. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This disruption interferes with Pierce2's role in maintaining microtubule structure, potentially leading to impaired cellular functions and processes dependent on microtubules. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $85.00 $220.00 $598.00 | 4 | |
Griseofulvin, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This interference with microtubule structure can lead to functional impairment of Pierce2, affecting cellular processes dependent on dynamic microtubules. | ||||||
Docetaxel | 114977-28-5 | sc-201436 sc-201436A sc-201436B | 5 mg 25 mg 250 mg | $87.00 $332.00 $1093.00 | 16 | |
Docetaxel, a microtubule-stabilizing agent, indirectly inhibits Pierce2 by promoting microtubule stability. Enhanced microtubule stability interferes with Pierce2 function, potentially affecting cellular processes relying on dynamic microtubule structures. | ||||||
Epothilone B, Synthetic | 152044-54-7 | sc-203944 | 2 mg | $176.00 | ||
Epothilone B, a microtubule-stabilizing agent, indirectly inhibits Pierce2 by promoting microtubule stability. Enhanced microtubule stability interferes with Pierce2 function, potentially affecting cellular processes relying on dynamic microtubule structures. | ||||||
Vinorelbine base | 71486-22-1 | sc-205885 sc-205885A sc-205885B sc-205885C sc-205885D | 1 mg 5 mg 25 mg 100 mg 1 g | $29.00 $81.00 $260.00 $791.00 $1977.00 | ||
Vinorelbine, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This interference with microtubule structure can lead to functional impairment of Pierce2, affecting cellular processes dependent on dynamic microtubules. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Podophyllotoxin, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This interference with microtubule structure can lead to functional impairment of Pierce2, affecting cellular processes dependent on dynamic microtubules. | ||||||
Vinflunine | 162652-95-1 | sc-507411 | 10 mg | $390.00 | ||
Vinflunine, a microtubule-depolymerizing agent, directly inhibits Pierce2 by disrupting microtubule dynamics. This interference with microtubule structure can lead to functional impairment of Pierce2, affecting cellular processes dependent on dynamic microtubules. | ||||||